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Molecular Analysis of T-Cell Receptor b Genes in
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Suzanne M. Morgan1, Elizabeth Hodges1, Tracey J. Mitchell2, Susan Harris1, Sean J. Whittaker2
and John L. Smith1
Molecular characterization of T-cell receptor junctional region sequences in cutaneous T-cell lymphoma had
not been previously reported. We have examined in detail the features of the T-cell receptor beta (TCRB) gene
rearrangements in 20 individuals with well-defined stages of cutaneous T-cell lymphoma (CTCL) comprising 10
cases with early-stage mycosis fungoides (MF) and 10 cases with late-stage MF or Sezary syndrome. Using
BIOMED-2 PCR primers, we detected a high frequency of clonally rearranged TCR gamma and TCRB genes (17/
20 and 15/20 cases, respectively). We carried out sequencing analysis of each complete clonal variable
(V)b–diversity (D)b–joining(J)b fingerprint generated by PCR amplification, and determined the primary structure
of the Vb–Db–Jb junctional regions. We observed considerable diversity in the T-cell receptor Vb gene usage and
complementarity-determining region 3 loops. Although we found that TCRB gene usage in CTCL and normal
individuals share common features, our analysis also revealed preferential usage of Jb1 genes in all cases with
advanced stages of disease.
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INTRODUCTION
Cutaneous T-cell lymphomas (CTCL) are mature indolent
T-cell neoplasms that arise from malignant, clonal proliferation
of T cells. Mycosis fungoides (MF) and Sezary syndrome (SS)
represent the major variants of CTCL. MF, the most common
form, is a neoplasm of cerebriform skin homing T lympho-
cytes that consists of erythematous patches and plaques and
approximately 25% of patients will develop tumors and
lymph node involvement, and will die of their disease
(Rappaport and Thomas, 1974; Diamandidou et al., 1996;
Willemze et al., 1997). SS is most commonly defined by
infiltrated erythroderma accompanied by circulating Sezary
cells and lymphadenopathy (Diamandidou et al., 1996;
Willemze et al., 1997). Clonally rearranged T-cell receptor
(TCR) genes are a molecular hallmark of CTCL, and the
unique TCR fingerprint of the neoplastic cell population
provides an important diagnostic correlate (Delfau-Larue
et al., 1998b; Wood, 2001). The etiology of the disease
remains unknown, although several causative factors for
CTCL have been proposed and investigated, including infec-
tious agents (Zucker-Franklin and Pancake, 1994; Jackow
et al., 1997; Wood et al., 1997) and environmental factors
(Tuyp et al., 1987; Whittemore et al., 1989). Molecular
abnormalities have been identified in CTCL, but unlike nodal
lymphomas, disease-specific chromosomal abnormalities
have not yet been identified (Thangavelu et al., 1997; Mao
et al., 2003). The majority of malignant cells in CTCL have
the phenotype of T-helper memory lymphocytes, ab-TCRþ ,
CD2þ , CD3þ , CD4þ , and CD45ROþ (Kung et al., 1981;
Sterry and Mielke, 1989; Freedman and Nadler, 1991), and
express the skin homing cutaneous lymphocyte antigen
raising the hypothesis that malignancy in CTCL is initiated
by chronic antigenic stimulation of T-cell clones that
subsequently fail to undergo cell death.
During lymphocyte maturation, TCR variable (V) domain-
encoding exons are assembled by DNA recombination of V,
diversity (D) (b chain only), joining (J), and constant region
segments that are encoded as noncontiguous elements within
the germ line (reviewed by Davis and Bjorkman, 1988).
Structural constraints imposed by the recognition of immu-
nodominant antigens would select a restricted number of
TCRs that exhibit at least some common features. The
specificity of T-cell recognition is determined by the V
domain of the TCRa- and b-chains. The rearrangment of V, D,
and J region segments creates D at the complementarity-
determining region 3 (CDR3). Variations in the particular V,
D, and J elements used, precise points of recombination,
random non-genomic N region nucleotide addition, deletion
of nucleotides by trimming the ends of the involved V, D, and
J regions and templated P nucleotide additions all lead to
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extensive sequence and length heterogeneity in the CDR3
(Chothia et al., 1988; Davis and Bjorkman, 1988; Wilson
et al., 1988), and hence enormous diversity in the TCR
repertoire. Each individual CDR3 of the TCR is unique and
can serve as the molecular signature for the corresponding
disease-specific T-cell clones. Superantigens can also selec-
tively stimulate large populations of T cells expressing
particular TCRVb gene segments without the contribution of
the other V elements (Db, Jb, Va, and Ja) (Kappler et al., 1989;
Marrack and Kappler, 1990).
There is some evidence for the involvement of super-
antigen in driving T-cell expansion in CTCL (Jackow et al.,
1997, Linnemann et al., 2004). Clonal TCR beta (TCRB)
rearrangements in MF have shown broad TCRVb usage with
no evidence for oligoclonal T cells with restricted Vb gene
usage but the primary structure of the hypervariable CDR3
loops and J gene usage has not been determined (Whittaker
et al., 1991; Bahler et al., 1992; Gorochov et al., 1995; Thor
et al., 1998). As a result of the significance of restricted TCRB
usage for the development, diagnosis, and therapy of disease,
we have probed further the TCR gene usage in CTCL. We
have carried out detailed molecular characterization of the
TCRB rearrangements in individuals with well-defined stages
of CTCL, early-stage MF (1A–1B) late stage MF (IIB–IVA) and
SS. T-cell clonality in lesional skin biopsies was analyzed by
PCR using primers that cover all functional TCR Vb and Jb
gene segments, and the majority of TCR gamma (TCRG) gene
rearrangements (van Dongen et al., 2003). In each case,
the complete clonal Vb–Db–Jb fingerprint generated was
analyzed by nucleotide sequencing. TCRVb and Jb gene
usage was assigned, and the primary structure of the CDR3
regions determined.
RESULTS
We investigated 27 DNA samples (20 extracted from skin
biopsies and seven from lymph nodes) from 20 patients with
a clinical diagnosis of primary cutaneous T-cell lymphoma
(Table S1). Seventeen cases with MF were selected, 10
patients (46–87 years) with patch or plaque-type cutaneous
lesions (early-stage MF, stages 1A–1B), and seven patients
(28–82 years) with cutaneous tumors, some having lymph
node involvement (late stage MF, stages IIB–IVA). Three
patients with SS were also selected, two showing histologic
lymph node involvement (IVA).
Clonality in TCRG gene usage was detected in eight of
10 patients with early-stage MF, in all seven patients with
advanced stage MF and two of three SS patients (Figure 2). In
matching skin and lymph nodes sets, identical clonal TCRG
PCR products were amplified for five out of five MF patients,
and in one of two SS. In the remaining SS case, different
TCRG clonal products were amplified in the skin and lymph
node (data not shown). In 15 cases, the frequent Vgf1–Jg1.3/
2.3 or Vg9–Jg1.3/2.3 rearrangements were detected, with the
remaining two cases utilizing Vgf1–Jg1.1/2.1 rearrangements.
Complete Vb–Db–Jb rearrangements were detected in six
of 10 patients with early-stage MF, in all patients with late
stage MF, and in two of three patients with SS (Figures 1 and
2). Clonal rearrangements utilizing Jb1 family segments were
detected in three cases with early-stage MF and in all cases
with late-stage MF and SS. Clonal rearrangements utilizing
Jb2 family segments were amplified in five cases with early-
stage MF and one case with late-stage MF. Two clonal TCRB
PCR products were detected in six cases. Incompletely
rearranged alleles in the Db–Jb1 and Db–Jb2 clusters occurred
with a higher frequency in early-stage than in late-stage MF
(10/18 and 4/16, respectively). Where clonal Vb–Db–Jb
rearrangements were not detected, those cases were subse-
quently excluded from further analysis; in patients 1, 3, and
18, polyclonal populations were detected, and, in patients
4 and 9, TCR clonality was detected only for TCRG and
partial Db–Jb rearrangements. Where clonal TCRB gene
rearrangements were detected in the lymph nodes (four of
seven cases), identical clonal rearrangements were detected
in matching skin (data not shown).
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Figure 1. Fluorescent TCR Genescan analysis. Representative TCRB multiplex Genescan analysis of DNA extracted from skin biopsies from patients with CTCL.
(a and b) Demonstrate a polyclonal Gaussian distribution with the TCRB A mix and TCRB mix, respectively, (c and d) demonstrate V–Jb2 clonal rearrangements
in patients 5 and 6, respectively, (e and g–j) demonstrated V–Jb1 clonal rearrangements in patients 7, 13, 16, 17, and 18, and (f) demonstrates biallelicV–JB1
clonal rearrangements in patient 11.
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Vb–Db–Jb gene rearrangements were sequenced in those
cases where single product peaks were detected in the TCR
Vb–Jb1 or TCR Vb–Jb2 PCR reactions (denoted R in Figure 2)
by Genescan analysis. Using individual TCRVb family-
specific primers, the single PCR products could be amplified
in the absence of a polyclonal background. This facilitated an
efficient cloning rate, and allowed the easy identification of
clonal TCRB gene usage without the need to sequence a high
number of clones. In those cases where two TCRB
rearrangements were amplified, sequencing revealed that
only one TCRb allele was fully translated, indicating the
presence of a clonal T-cell population. Following sequence
comparison with the public IMGT database, TCRB usage
was assigned (Figures 3 and 4). The boundary between the
V segments and the junctional region of the clonal TCRB
rearrangements was assigned according to the consensus
defined by Breit and van Dongen (1994), and the nucleotide
and protein sequences of these CDR3 regions are presented
in Figures 4 and 5, respectively. Sequence analysis confirmed
the restricted usage of Jb1 family segments in clonal TCRB
rearrangements of late-stage MF and SS. Individual TCRBJ
usage was nonrandom, with usage of the TCRBJ1 and TCRBJ2
clusters restricted to gene segments J1S1, J1S2, J1S3 and J1S5,
and J2S7, respectively. No preferential usage of particular
Vb gene families was observed. Extensive trimming occur-
red during most of the TCRB recombinations. In all cases,
however, the D segments could be assigned to given clusters.
In rearrangements expressing the TCRBJ1 cluster, all were
found to use the TCRBD1 segment. Where the TCRBJ2 cluster
was expressed, either the TCRBD1 or TCRBD2 segment was
used. We did not detect any TCRBD2–BJ1 J events. The over-
all average CDR3 length was 5.7 amino acids, ranging from
3 to 8 amino acids, with frequent use of G, S, T, R, A, and L.
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Figure 2. Detection of clonal TCRG and TCRB gene rearrangements in the
skin of CTCL patients by PCR.
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Underlined sequences: germline TCRD1 and TCRD2 sequences.
Patient 2: nine clones were sequenced. Every clone used V2S1, and six clones utilized the same J gene segment (J 1.2). Junctional N-D-N sequences  were different
for each of the nine clones. Junctional sequence is shown for a seleceted clone.
Patient 6 and 20: eight clones were sequenced. 
Patient 6: stop codon introduced in the N region.
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Figure 3. Junctional region nucleotide sequences in clonal TGR Vb–Db–Jb gene rearrangements in CTCL.
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Figure 4. Junctional amino-acid sequences in clonal TCR Vb–Db–Jb gene
rearrangements in CTCL.
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Figure 5. TCRB junctional amino-acid sequences of nine clones amplified
from the skin lesion of patient 2.
www.jidonline.org 1895
SM Morgan et al.
TCRB Gene Rearrangements in CTCL
There was no evidence of a consensus amino-acid motif in
the CDR3 regions.
In a single case (patient 2), sequencing revealed a
polyclonal expansion of T cells that shared the same Vb
gene family (TCRVb2S1). The polyclonal nature of this
sample was not evident by Genescan analysis. Each of nine
clones sequenced used Vb2S1, but all clones exhibited
different junctional N-b-N sequences, including six clones
with a shared Jb gene segment (Figure 5). In two remaining
cases where clonal TCRB gene rearrangements were detected
by Genescan analysis, we did not determine the functional
Vb–Db–Jb rearrangement. In the first case (patient 6), a
stop codon was introduced in the N region (Figure 3), and in
the second case (patient 20), an inframe J chain was not
identified (Figure 4). We considered whether non-template
nucleotides had been introduced by Taq errors. However,
on repeating the amplification, cloning and sequencing in
both cases, identical primary sequences were obtained, thus
implying the amplification of non-functional TCRB rearrange-
ments known to occur rarely in some T-cell malignancies as
well as in normal peripheral blood T cells (Langerak et al.,
2001).
DISCUSSION
The monoclonal nature of CTCL is evident in the earliest
histologically recognizable lesions and indeed we detected
clonal T-cell populations in both early- and late-stage disease
(Weiss et al., 1989; Mielke et al., 1994; Wood et al., 1994;
Bachelez et al., 1995; Theodorou et al., 1995; Muche et al.,
1997; Delfau-Larue et al., 1998a, b, 2000; Beylot-Barry et al.,
2001). Clonal TCRG gene rearrangements were detected in
85% (17/20) of cases (three cases had polyclonal infiltrates).
Furthermore, in our series of paired skin and lymph node
biopsies (five MF and two SS), we detected matched clonal
TCRG gene rearrangements in all patients with MF (IIB–IVA)
and in one of two patients with SS. In the single SS case,
different clonal TCRG rearrangements were detected, con-
sistent with clonal heterogeneity known to occur at different
anatomical sites in some CTCL cases (Bignon and Souteyr-
and, 1990; Lynch et al., 1992; Vega et al., 2002). TCRG is
not lineage specific and is rearranged at an early stage of
T-lymphoid development in TCRab as well as TCRgd
lineages. Our detection rate of TCRG clones in CTCL is at
least as high as that reported in the literature. In mature
TCRab T-cell malignancies, TCRG rearrangements are detec-
ted in 490% of T cell large granular lymphocyte leukemia,
T-cell acute lymphoblastic leukemia, and T-cell prolympho-
cytic leukemia, 50% of peripheral T cell non-Hodgkin’s
lymphoma, and 76% of MF (Sandberg et al., 2003; van
Dongen et al., 2003). We found that clonal TCRG gene
rearrangements were accompanied by clonal TCRB gene
rearrangements in the majority of cases (14/17 cases). In two
cases (patients 4 and 9), clonally rearranged TCRG alleles
were detected in the absence of complete clonal Vb–Db–Jb
rearrangements. However, in these two patients we detected
complete clonal Vd–Jd rearrangements (data not shown). Such
patterns of TCRgd gene rearrangements would be consistent
with TCRgd clonal expansions which has been previously
described in CTCL (Ralfkiaer et al., 1992; Toro et al., 2000).
In the third case (patient 2) capillary electrophoresis did not
resolve the PCR products amplified from the polyclonal
Vb2þ -T-cell infiltrate by the TCRB primers.
In advanced MF and SS, we noted a previously unreported
bias in favor of the TCRB1 cluster, with all cases utilizing Jb1
family genes. In general, the Jb2 family is represented
more commonly than the Jb1 family in the TCR repertoire
of healthy individuals suggesting that this is not likely to be
a chance finding (Quiros et al., 1995). In addition, Vb–Jb2
clonal rearrangements are detected more frequently in
mature TCRabþ T-cell malignancies compared with im-
mature TCRabþ T-cell acute lymphoblastic leukemia, with
Vb–Jb2/Vb–Jb1 ratios of 2.7 and 0.9, respectively (Langerak
et al., 1999). Furthermore, we (Smith et al., 2000) and others
(M. Bruggeman, personnel communication) have found that
the frequency of TCRBJ1 and TCRBJ2 cluster usage in other
mature TCRab T-cell malignancies (e.g. angioimmunoblastic
lymphadenopathy, T-cell large granular lymphocyte leuke-
mia, T-cell prolymphocytic leukemia, and peripheral T-cell
lymphoma) is similar or biased towards TCRBJ2 gene usage.
Individual TCRB J segments were not assigned in these
studies. Thus, our findings on restricted TCRB1 cluster usage
in the T-cell clones in advanced stage MF and SS may be a
reflection of an abnormal T-cell repertoire in this disease.
Indeed, there is some evidence to suggest that the complexity
of the T-cell repertoire is disrupted in CTCL. TCRB CDR3
spectratyping of peripheral blood T cells from 20 MF patients,
have revealed dramatic skewing and restriction of the normal
peripheral blood TCR repertoire in all cases of advanced
stage disease and in 50% of patients with early-stage disease,
but Jb gene usage was not investigated (Yawalkar et al.,
2003). It would be interesting to extend this study, and
establish whether there is an under-representation of Jb2
family subsets in the normal peripheral blood T-cell reper-
toire in CTCL patients. There is a precedent for an inverted
Jb1 bias and an associated reduction in T-cell complexity in
hematological disorders (Nagano et al., 1999). In familial
hemophagocytic lymphohistiocytosis, a rare disorder of
the mononuclear phagocyte system, there is evidence for a
marked bias towards Jb1 subsets in the preferentially
expanded T-cell populations (Jb2:Jb1 was 13:87 in 65% of
the ab-T cells) (Nagano et al., 1999). The authors speculate
that the bias in Jb1 cluster usage might influence T-cell
dysfunction in the disease.
Analysis of the junctional Vb–Db–Jb fingerprint generated
for each patient demonstrated common features of TCRB
rearrangements in CTCL and normal individuals. The junc-
tional region amino-acid content in CTCL was similar to that
reported for the mature TCR repertoire in healthy individuals.
Amino-acid residues G, S, T, R, A, and L were present at a
high frequency in CTCL, in accordance with previous
findings on their extensive usage within the TCRB CRD3
region of normals (Breit and van Dongen, 1994; Quiros et al.,
1995). Five of the available 13 TCRB J segments (J1S1, J1S2,
J1S3, J1S5, and J2S7) were utilized in the CTCL cases. This
nonrandom pattern of J region usage has also been described
for healthy individuals, where a number of TCRB J segments
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are preferentially utilized (Jeddi-Tehrani et al., 1994; Hall and
Lanchbury, 1995; Quiros et al., 1995). Similarly, we found
that the D–J cluster usage in CTCL reflects that seen in normal
T cells (Quiros et al., 1995), with TCRBD1–BJ1, TCRBD1–BJ2,
and TCRBD2–BJ2 J events identified. Taken together, these
findings suggest that typical recombination events in TCRB
rearrangements occur in CTCL ‘‘precursor’’ T cells.
Our data did not detect preferential usage of particular
Vb gene families. TCRVb gene usage in the malignant clonal
T-cell population was random, with expression of b2S1, -3S1,
-5S1, -6S3, -11S1, -12S2, -13S1, -13S3, -17S1, -20S1, and
-21S1. While Vb2S1 and Vb20S1 were utilized by three and
two patients, respectively, in each case the TCRB rearrange-
ment involved different Jb segments. Furthermore, we found
no evidence for a common CDR3 motif.
Our study reveals the possible involvement of super-
antigen-driven T-cell expansion in some individuals. In one
case with early stage MF (patient 2), a polyclonal Vb2S1-
positive T-cell population was detected in the lesional skin
biopsy, indicating a role for a superantigen in driving the
expansion of the T-cell infiltrate. All clones analyzed
expressed the Vb2S1 gene but had highly diverse junctional
regions. T cells that expand in response to superantigen
stimulation exhibit a high diversity of the TCRb V–D–J junc-
tional segments in terms of amino-acid length and protein
sequence (Leung et al., 1995; Musette and Bachelez, 1997).
Failure to amplify a dominant clonal TCRB fingerprint against
the polyclonal expansion of Vb2S1-positive T cells in patient
2 might suggest the absence of an established transformed
clone. Thus, tracking the emergence of a dominant T-cell
clone in this individual may prove important in establishing
an etiological role for superantigen. Superantigens stimulate
large populations of helper T cells expressing particular
TCRVb chain gene segments (Kappler et al., 1989; White
et al., 1989; Takimoto et al., 1990). TSST-1, the bacterial
superantigen, is associated with amplification of TCR Vb2
(Choi et al., 1989; Abe et al., 1992), and it has previously
been reported that Vb2-positive T cells were overexpanded
in Sezary patients who had associated infection with toxic
shock syndrome toxin-1-positive Staphylococcus aureus
(Jackow et al., 1997; Linnemann et al., 2004). A recent
case study provided further evidence for the involvement of
superantigen in CTCL (Linnemann et al., 2004). In a patient
that was diagnosed with early-stage MF, the dominant Vb5.1-
positive T-cell population found in skin lesions was poly-
clonal, as determined by sequence analysis of TCRVg
rearrangements. Thus, in some CTCL cases chronic stimula-
tion of T cells by superantigen may be the critical factor in
disease progression. This is consistent with recent evidence
demonstrating that malignant transformation can be driven
by chronic inflammatory responses (Balkwill and Coussens,
2004).
We have carried out a detailed analysis of the functional
TCRB rearrangements in a group of patients with well-defined
stages of CTCL. The lack of shared/restricted Vb family usage
and CDR3 motifs indicates that a common antigen is not
involved in this disease. However, our data on the polyclonal
expansion of Vb2S1-positive T cells in one individual with
early-stage disease suggests a role for superantigen in CTCL
pathogenesis. We show a strong association between Jb1
usage and disease severity in CTCL, and understanding
the functional significance of this finding for the progress of
CTCL is the subject of further investigation.
MATERIALS AND METHODS
Samples
Twenty cases with a diagnosis of primary CTCL were selected for this
retrospective study on TCRb gene usage. The clinical and
phenotypic features of the patients are shown in Table S1. DNA
was isolated from routine lesional skin and lymph node biopsies,
both fresh and paraffin-embedded sections, using a commercial kit
according to the manufacturers’ instructions (QIAamp DNA Blood
Kit; Qiagen, UK). All cases were seen and followed at St John’s
Institute of Dermatology, Guys and St Thomas’ Hospital, London.
Diagnoses were made according to the EORTC classification
(Willemze et al., 1997) for primary cutaneous lymphoma, which is
based on a combination of clinical, histological, immunopheno-
typic, and molecular critria. Approval to process these samples was
obtained from the Southampton and South West Hampshire ethics
committee (UK 047/03/t) and the study was conducted according to
the Declaration of Helsinki Principles.
Identification of clonal TCR gene rearrangements
In all cases, DNA was successfully extracted and amplified. Clonal
TCRB and TCRG gene rearrangements were assessed by PCR using
primers and protocols developed within the BIOMED-2 BMH4-
CT98-3936 Concerted Action initiative (van Dongen et al., 2003).
TCRB rearrangements were assessed using three multiplex reactions
that target the V, D, and J regions. To detect complete Vb–Db–Jb
gene rearrangements, a mixture of 23 50 Vb primers was combined
with two sets of 30 fluorescent-labelled Jb primers (Jb1.1–1.6, Jb2.2,
Jb2.6 and Jb2.7, or Jb2.1, Jb2.3, Jb2.4 and Jb2.5); carboxyfluorescein
and hexachlorofluorescein were used to label Jb1 and Jb2 primers,
respectively. The 23 Vb primers cover approximately 90% of all Vb
gene segments. Partial TCRB D–J gene rearrangements were detected
using one multiplex reaction containing Db1, Db2, and the 13
fluorescently labelled Jb primers. The TCRB multiplex analysis
affords a 94% clonal detection rate in Southern blot-defined T-cell
malignancies (van Dongen et al., 2003). TCRG gene rearrangements
were detected using two multiplex reactions containing 50 Vg
primers in combination with two fluorescent-labelled 30 Jg primers
(carboxyfluorescein-Jg1.1/2.1 and hexachlorofluorescein-Jg1.3/2.3).
All primers were purified by high-performance liquid chromato-
graphy (Invitrogen Life Technologies, UK). In all cases, PCR was
carried out in a 50-ml reaction volume with 200 ng DNA, 10 pmol of
each primer, 0.2 mM deoxynucleotide triphosphates, Gold buffer,
2 U AmpliTaq Gold polymerase (Applied Biosystems, UK), and
1.5–3 mM MgCl2, and amplified as follows: initial denaturation for
10 minutes at 941C, followed by 35 cycles of 1 minute at 941C,
1 minute at 601C, and 1 minute at 721C, with a final extension step of
10 minutes at 721C. For polyclonal and clonal controls, DNA
isolated from tonsil or tumor tissue with defined clonal infiltrates was
included as template. Reactions carried out in the absence of
template acted as negative controls. Analysis of PCR products was
performed by Genescan analysis. One microliter of PCR product was
diluted 10-fold in formamide-containing ROX-400 DNA standard
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(Applied Biosystems) and denatured (951C for 5 minutes) prior to
separation in a high-resolution denaturing polyacrylamide gel (POP4
polymer; Applied Biosystems) and detection via a scanning laser
using an automated ABl Prism 3100 Genetic Analyser. A normal
Gaussian size distribution of multiple peaks representing many
different PCR products characterizes a polyclonal lymphoprolifera-
tion, whereas single product peaks are representative of a mono-
clonal lymphoproliferation (Figure 1).
Sequence analysis of clonal TCRB gene rearrangements
Complete TCRB gene rearrangements were sequenced in those cases
where single-product peaks were detected in the multiplex TCRB
Vb–Jb1 or TCR Vb–Jb2 PCR reactions by Genescan analysis.
Individual TCRVb family-specific primers and pooled Jb primers
were combined in 24 separate reactions followed by Genescan
analysis. Using this strategy, specific PCR products could be
generated and detected without amplification from a polyclonal
background and were subsequently ligated with the pCR2.1TM
plasmid (TA cloning kit; Invitrogen Life Technologies, UK) and
amplified in E. coli (TOP10F’); single-product peaks generated
mirrored those detected in the multiplex PCR reactions. Plasmids
carrying the correct inserts were purified (Qiaprep spin mini kit,
Qiagen, UK) for sequencing. Gene usage was assigned where at least
70% of clones shared an identical sequence. Sequencing was
performed on both strands using M13 universal primers and the
BigDye terminator V1.1 cycle sequencing kit (Applied Biosystems,
UK), with separation in a high-resolution denaturing polyacrylamide
gel (POP4 polymer; Applied Biosystems) and detection via a
scanning laser on an automated ABl Prism 3100 Genetic Analyser.
Sequence comparison with the international Immunogenetics
database (http://imgt.cines.fr, initiator and coordinator: M-P LeFranc,
Montpellier, France) was performed using NCBI BLAST version 2.
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